中文产业新闻精选评分52Chinese source
罗氏退还 Emugrobart 给中外制药，同日启动 Petrelintide 三项 III 期临床
速递｜罗氏同日减重大洗牌：砍掉增肌老药，七千人三期临床押注新机制
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
速递｜罗氏同日减重大洗牌：砍掉增肌老药，七千人三期临床押注新机制
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.